Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Recordati SpA

All Over For Asarina With No Partner Found For Tourette's Drug

Sepranolone may have progressed positively through a Phase IIa trial but its potential to reduce tics has failed to tempt any of the 20 or so potential partners that the Swedish biotech spoke to about a licensing deal.

Neurology Business Strategies

Chiesi Takes Long View To Build Japan Rare Disease Presence

After expanding its local portfolio through acquisitions and partnerships, Chiesi is now aiming to build its presence in Japan's rare disease sector over the long term, helped by development of global products and possible new alliances. 

Japan Rare Diseases

New Oncologics Overwhelmingly Approved In US Before EU

Ninety-five percent of novel cancer treatments approved in both the US and Europe received the FDA’s OK first, but Europe usually followed within a year, a Pink Sheet analysis shows.

Regional Comparisons Approvals

Ligand Makes Second Big Oncology Investment In 2024 With Apeiron Buyout

The company is acquiring rights to royalties from Qarziba, a neuroblastoma drug approved in ex-US markets that Recordati develops and markets in all of them except mainland China.

Deals Cancer
See All

Company Information

  • Industry
  • Distributors
  • Pharmaceuticals
  • Pharmaceuticals
    • OTC, Consumer
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • Bouchara Recordati
    • Dr. F. Frik Ilaç A.S.
    • Opalia Pharma S.A.
    • Orphan Europe
    • Recordati Pharmaceuticals Ltd.
    • Laboratorios Casen Fleet
    • Italchimici S.p.A.
    • Pro Farma AG
    • Recordati S.A. Chemical and Pharmaceutical Company
    • Recordati Rare Diseases Canada Inc.
    • Natural Point S.r.l.
    • Tonipharm S.A.S.
    • FIMEI S.p.A
    • Rossini Investimenti S.p.A
UsernamePublicRestriction

Register